Literature DB >> 21340520

Posterior reversible encephalopathy syndrome following disulfiram intoxication.

Sandra Coppens, Gilles Naeije, Nicolas Mavroudakis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21340520     DOI: 10.1007/s00415-011-5945-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Lesions of basal ganglia due to disulfiram neurotoxicity.

Authors:  D Laplane; N Attal; B Sauron; A de Billy; B Dubois
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

Review 2.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 3.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

4.  Posterior reversible encephalopathy syndrome in chronic alcoholism with acute psychiatric symptoms.

Authors:  Ryo Kimura; Makoto Yanagida; Aki Kugo; Satoki Taguchi; Hidenori Matsunaga
Journal:  Gen Hosp Psychiatry       Date:  2009-12-16       Impact factor: 3.238

Review 5.  [Disulfiram (Esperal) toxicity. Apropos of 3 original cases].

Authors:  O Dupuy; F Flocard; C Vial; G Rode; N Charles; D Boisson; A Flechaire
Journal:  Rev Med Interne       Date:  1995       Impact factor: 0.728

6.  Catecholamines and the relationship between cerebral blood flow and glucose use.

Authors:  U I Tuor; L Edvinsson; J McCulloch
Journal:  Am J Physiol       Date:  1986-10

7.  Differentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolism.

Authors:  P N Karamanakos; P Pappas; P Stephanou; M Marselos
Journal:  Pharmacol Toxicol       Date:  2001-02
  7 in total
  1 in total

1.  Posterior Reversible Encephalopathy Syndrome Instigated by Off-Label Disulfiram Use for Metastatic Melanoma.

Authors:  David R Beam; Jennifer M Knight
Journal:  Psychosomatics       Date:  2019-09-17       Impact factor: 2.386

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.